Anest. intenziv. Med. 2009;20(1):31-35

Guidelines for the treatment of invasive fungal infections in immunocompromised patientsGuidelines

Haber Jan1,*, Mayer Jiří2, Drgoňa Luboš3
1 I. interní klinika - klinika hematologie VFN a 1. LF UK Praha
2 Interní hematoonkologická klinika, FN Brno a LF MU v Brně
3 Národný onkologický ústav, Bratislava, Slovensko

A national working group representing clinicians, microbiologists, and different specialist medical societies and working groups prepared evidence-based guidelines for the treatment of established invasive fungal infections. In this article, the first one of a series of three, the evidence criteria of the Infectious Diseases Society of America (IDSA) used for assessing the quality of clinical trials, and EORTC/MSG Consensus Group for definitions of invasive fungal disease, are presented.

Keywords: guidelines; invasive fungal infection

Published: February 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Haber J, Mayer J, Drgoňa L. Guidelines for the treatment of invasive fungal infections in immunocompromised patients. Anest. intenziv. Med. 2009;20(1):31-35.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cordonnier, C., Calandra, T. The first European conference on infections in leukaemia: Why and how? European Journal of Cancer Supplements, 2007, 5, p. 2-4. Go to original source...
    2. Kish, M. A. Guide to development of practice guidelines. Clin. Infect. Dis., 2001, 32, p. 851-854. Go to original source... Go to PubMed...
    3. Dykewicz, C. A. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clin. Infect. Dis., 2001, 33, p. 139-144. Go to original source... Go to PubMed...
    4. Ascioglu, S., Rex, J. H., de Pauw, B. et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis., 2002, 34, p. 7-14. Go to original source... Go to PubMed...
    5. De Pauw, B., Walsh, T. J., Donnelly, J. P. et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis., 2008, 46, p. 1813-1821. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.